Zinzino AB (STO: ZZ B) is a Gothenburg-based direct seller of test-based personalized nutrition, listed on Nasdaq First North Growth Market since 2014 and trading at around SEK 135. Most serious investors scroll right past it. It's a direct seller, multi-level marketing, network sales, pick whichever label trips your gag reflex, that ships fish oil and personalized supplements through an army of independent distributors. The three letters "MLM" do an enormous amount of work scaring capital away.
That reflex is the whole opportunity. Strip the label off and read the statements, and you find a debt-free, cash-generative business that has compounded operating profit at roughly 45% a year for five years, earns a ~48% return on invested capital, and trades at about 14× earnings with a 4%-plus dividend. So one of two things is true. Either the market is right that this is a fragile pyramid about to topple — or it’s mispricing a genuinely good business because of the company it keeps. This is my attempt to settle that with numbers, not adjectives.
